Skip to Content

  • Search

View Additional Section Content

Cancer Clinical Trials

Patients at The Rosenfeld Cancer Center have opportunities to access new cancer treatments and methods through our participation in clinical trials.

Supervised by our oncology physicians and clinical research staff, these studies benefit our patients with innovative developments before those approaches are widely available.

Our participation in clinical trials means that promising new advances, often accessible only at university medical centers, are available to our patients right in our community. Abington Health’s Center for Clinical Research oversees all patient-centered research and clinical trials. 

Cancer Clinical Trials

We take part in studies from the National Institutes of Health (NIH), National Cancer Institute (NCI) and cancer research groups including: Eastern Cooperative Oncology Group (ECOG); Radiation Therapy Oncology Group (RTOG); Gynecologic Oncology Group (GOG); and American College of Surgeons Oncology Group (ACOSOG).

Through our association with the Cancer Trials Support Unit (CTSU), we also have access to trials from other leading cancer research groups such as the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the National Cancer Institute of Canada (NCIC).

See some of our current and recent cancer clinical trials on the right.

Enrolling in Clinical Trials

Your medical oncologist, gynecologic oncologist, radiation oncologist, surgical oncologist or one of our other specialists can talk with you about available clinical trials that might be appropriate for your diagnosis. Your cancer navigator will help you with information on study specifics and the enrollment process.

To find out the latest information about cancer clinical trials at The Rosenfeld Cancer Center, call the oncology research coordinator at 215-481-2402.

Managing Ovarian Cancer Through Clinical Trials

Read one woman's story of managing her ovarian cancer by participating in clinical trials.

Read Nancy's Story


Blue Distinction Complex and Rare CancersCoC Outstanding Achievement Award 2012